logo

For the Inventor, By the Inventor

Greenwood, IN, United States of America

Ian G Wright

This inventor holds 10 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1976-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian G Wright. Retrieved from https://idiyas.com/inventor/ian-g-wright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal10 out of 4,514 
 
Eli Lilly and Company
 patents

Years Active: 1976-1991

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5030725 - Method of resolving cis (1991-07-09),
2. 4923983 - Method of resolving cis (1990-05-08),
3. 4539422 - Process for preparing cephalosporin intermediates (1985-09-03),
4. 4223134 - Process for preparing cephalosporin antibiotics (1980-09-16),
5. 4171310 - N,N'-dichlorobicyclo[2.2.2]oct-7-ene-2,3,5,6 (1979-10-16),
6. 4148817 - Process and intermediates for preparing cephalosporin antibiotics (1979-04-10),
7. 4122082 - 4-Desacetoxy-4-oxovinblastine (1978-10-24),
8. 4008231 - Preparation of 3-methoxymethylcephalosporins (1977-02-15),
9. 3988325 - 7-Carboxy or 2,2,2-trichloroethoxy carbonyl- cephalosporins (1976-10-26),
10. 3941781 - Preparation of 3-alkylthiomethyl cephalosporins (1976-03-02),

Title: Ian G Wright: Innovator in Pharmaceutical Chemistry

Introduction

Ian G Wright is a prominent inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on innovative methods for resolving complex chemical compounds.

Latest Patents

Among his latest patents, Ian has developed a method for resolving cis - Cis .alpha.,.alpha./.beta., .beta.-3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one via (-)-2,3:4,6-di-O-isopropylidene-2-keto-L-gulonic acid hydrate (DAG). Additionally, he has created a method for resolving cis - Cis .alpha..alpha./.beta..beta.-3-amino-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using optically active tartaric acid.

Career Highlights

Ian G Wright is currently employed at Eli Lilly and Company, where he continues to push the boundaries of pharmaceutical innovation. His expertise in resolving complex chemical structures has made him a valuable asset to the company.

Collaborations

Ian has collaborated with notable colleagues, including Norbert Neuss and John Allan Rieck, III. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Ian G Wright is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements. His contributions, particularly in resolving complex compounds, highlight his expertise and commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…